Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage control

Journal of Gene Medicine

Volumn 6, Issue 10, 2004, Pages 1159-1169

  Fux, Cornelia ^a,b   Langer, Dominik ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

^b Inotech SA   (Switzerland)

Author keywords

Adipocyctes; Differentiation; Dual regulation; Msx1; MyoD; Myotubes; Osteoblasts; Streptogramin; Tetracycline

Indexed keywords

CELL PROTEIN; MYOD PROTEIN; PRISTINAMYCIN; STREPTOGRAMIN; TETRACYCLINE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR MSX1; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC REGULATION; LIPOGENESIS; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; BONE AND BONES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HOMEODOMAIN PROTEINS; MICE; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; MSX1 TRANSCRIPTION FACTOR; MYOD PROTEIN; OSTEOCYTES; PHENOTYPE; TETRACYCLINE; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSGENES;

MAMMALIA;

EID: 4644373748     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.601     Document Type: Article

References (40)

1. Fussenegger M. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 2001; 17: 1-51.
2. Fussenegger M, Morris RP, Fux C, et al. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 2000; 18: 1203-1208.
3. Weber W, Fux C, Daoud-el Baba M, et al. Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol 2002; 20: 901-907.
4. Weber W, Schoenmarkers R, Spielmann M, et al. Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice. Nucleic Acids Res 2003; 31: e71.
5. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
6. Folcher M, Morris RP, Dale G, Salah-Bey-Hocini K, Viollier PH, Thompson CJ. A transcriptional regulator of a pristinamycin resistance gene in Streptomyces coelicolor. J Biol Chem 2001; 276: 1479-1485.
7. Hillen W, Klock G, Kaffenberger I, Wray LV, Reznikoff WS. Purification of the TET repressor and TET operator from the transposon Tn10 and characterization of their interaction. J Biol Chem 1982; 257: 6605-6613.
8. Fux C, Fussenegger M. Toward higher order control modalities in mammalian cells - independent adjustment of two different gene activities. Biotechnol Prog 2003; 19: 109-120.
9. Fux C, Moser S, Schlatter S, Rimann M, Bailey JE, Fussenegger M. Streptogramin- and tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells. Nucleic Acids Res 2001; 29: e19.
10. Moser S, Rimann M, Fux C, Schlatter S, Bailey JE, Fussenegger M. Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cells. J Gene Med 2001; 3: 529-549.
11. Rudnicki MA, Jaenisch R. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 1995; 17: 203-209.
12. Olson EN, Klein WH. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev 1994; 8: 1-8.
13. Buckingham ME. Muscle: the regulation of myogenesis. Curr Opin Genet Dev 1994; 4: 745-751.
14. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51: 987-1000.
15. Woloshin P, Song K, Degnin C, et al. MSX1 inhibits myoD expression in fibroblast x 10T1/2 cell hybrids. Cell 1995; 82 611-620.
16. Song K, Wang Y, Sassoon D. Expression of Hox-7.1 in myoblasts inhibits terminal differentiation and induces cell transformation. Nature 1992; 360: 477-481.
17. Odelberg SJ, Kollhoff A, Keating MT. Dedifferentiation of mammalian myotubes induced by msx1. Cell 2000; 103: 1099-1109.
18. Simon HG, Nelson C, Goff D, Laufer E, Morgan BA, Tabin C. Differential expression of myogenic regulatory genes and Msx-1 during dedifferentiation and redifferentiation of regenerating amphibian limbs. Dev Dyn 1995; 202: 1-12.
19. Lemercier C, To RQ, Carrasco RA, Konieczny SF. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD. EMBO J 1998; 17: 1412-1422.
20. Weber W, Kramer BP, Fux C, Keller B, Fussenegger M. Novel promoter/transactivator configurations for macrolide- and streptogramin-responsive transgene expression in mammalian cells. J Gene Med 2002; 4: 676-686.
21. Weintraub H, Davis R, Tapscott S, et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991; 251: 761-766.
22. Crescenzi M, Fleming TP, Lassar AB, Weintraub H, Aaronson SA. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc Natl Acad Sci U S A 1990; 87: 8442-8446.
23. Kitzmann M, Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci 2001; 58: 571-579.
24. Hughes SM. Muscle development: reversal, of the differentiated state. Curr Biol 2001; 11: R237-239.
25. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 1998; 16: 468-472.
26. Huang S. Gene expression profiling, genetic networks, and cellular states: an integrating concept for tumorigenesis and drug discovery. J Mol Med 1999; 77: 469-480.
27. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2000; 97: 11 307-11 312.
28. Rubanyi GM. The future of human gene therapy. Mol Aspects Med 2001; 22: 113-142.
29. Fussenegger M, Bailey JE. Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implications for biotechnology. Biotechnol Prog 1998; 14: 807-833.
30. Ye X, Rivera VM, Zoltick P, et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 1999; 283: 88-91.
31. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372-376.
32. Mitta B, Rimann M, Ehrengruber MU, et al. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 2002; 30: e113.
33. Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 2000; 7: 910-913.
34. Trono D. Lentiviral vectors for the genetic modification of hematopoietic stem cells. Ernst Schering Res Found Workshop 2001; 19-28.
35. Walsh K, Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev 1997; 7: 597-602.
36. Andres V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 1996; 132: 657-666.
37. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000; 57: 16-25.
38. Guo K, Wang J, Andres V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 1995; 15: 3823-3829.
39. Lassar AB, Skapek SX, Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 1994; 6: 788-794.
40. Olson EN. Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol 1992; 154: 261-272.